Home / Auditor changes / Arcadia Biosciences, Inc.
Filed 2026-04-03 路 Form 8-K 路 Accession 0001193125-26-142030 nano
Price before filing: $1.35 (2026-04-02 close, split/dividend-adjusted)
Market cap at flag: $1.8M (2026-04-02) 路 Latest: $225,456 (2026-10-16)
| Window | RKDA | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -11.1% | +9.5% | -20.6% | 2026-05-04 |
| 90 days | -45.7% | +13.9% | -59.6% | 2026-07-02 |
| 180 days | -79.3% | +16.9% | -96.1% | 2026-09-30 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
"(the "Company") dismissed Deloitte & Touche LLP ("Deloitte") as the Company's independent registered public accounting firm."
Quoted from the filing. Source
The company changed its outside auditor (8-K Item 4.01). A dismissal or resignation, especially near an annual report or with reported disagreements, is a warning sign. Changes caused by audit firms merging are usually routine.
Type: dismissed
Disagreements reported: no
Why this score: also within 90 days: Going-concern doubt
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.